Earnings Ahead

SGEN - Seattle Genetics

196.48 -0.06 -0.03

Seattle Genetics

Seattle Genetics

About

Profile

Founded 20 years ago, Seattle Genetics was built on a foundation of scientific innovation, rigorous research and drug development practices, as well as a passion for helping patients. Our leadership in antibody-drug conjugates (ADCs) and focus on innovati


Headquarters

Bothell, Washington, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

SGEN



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Seagen GAAP EPS of -$1.15 misses by $0.37, revenue of $571M misses by $64.1M
  • Pfizer CEO expects Seagen deal to close before year end, or early in 2024
  • Seattle Genetics Q3 2023 Earnings Preview
  • Pharma, PBMs spar over rising drug costs amid public scrutiny
  • Seagen, Genmab update Phase 3 data for uterine cancer therapy
  • Seagen/ Astellas succeed in Phase 3 trial for bladder cancer therapy
  • Seagen ticks higher as EU approves $43B sale to Pfizer
  • Pfizer likely turned over all documents to FTC for Seagen acquistion - report
  • Catalyst watch: Tesla earnings, Jerome Powell speech, UAW drama and Baidu event
  • Regulators looking at impact on innovation in review of Seagen/Pfizer - report
  • Pfizer expected to certify compliance with FTC on Seagen deal in 2-3 weeks - report
  • Merck succeeds in Phase 3 trial for bladder cancer therapy
  • Catalyst watch: Microsoft, Amazon, Oracle, and Intel to Hold High-Profile Events
  • 7 stocks to watch on Friday: Detroit Three automakers, Unity Software and more
  • Pfizer's $43B deal for Seagen gets European Union review
  • Seagen, Genmab succeed in Phase 3 trial for cervical cancer therapy
  • Horizon Therapeutics gains afer FTC settles with Amgen over $28B deal (update)
  • Horizon Therapeutics jumps after FTC pauses Amgen challenge for settlement talks
  • Horizon Therapeutics jumps as FTC withdraws in-house trial on $28B Amgen deal (update)
  • Seagen Tukysa combo breast cancer treatment successful in phase 3
PEERS
/XLV

XLV

Date Price Open High Low Vol Change
Dec 13, 2023 228.74 228.93
228.96
228.74
20.1M -0.07%
Dec 12, 2023 228.9 228.86
228.93
228.81
12.2M 3.29%
Dec 11, 2023 221.6 220
221.72
219
2.1M 1.20%
Dec 8, 2023 218.98 219
219.76
218.18
1.2M 0.30%
Dec 7, 2023 218.33 216
219.43
215.93
2.0M 1.17%
 
Dec 6, 2023 215.8 216.11
216.42
215.28
699K -0.01%
Dec 5, 2023 215.83 212.85
215.95
212.67
1.4M 1.27%
Dec 4, 2023 213.13 212.72
213.24
212.52
770K 0.19%
Dec 1, 2023 212.72 213.6
213.97
212.44
1.3M -0.23%
Nov 30, 2023 213.21 213.6
213.95
212.82
1.4M -0.15%
Nov 29, 2023 213.52 214.33
214.65
213.5
743K -0.3%
Nov 28, 2023 214.16 214.42
214.69
213.84
840K -0.12%
Nov 27, 2023 214.42 214.5
214.96
214.05
758K -0.01%
Nov 24, 2023 214.45 213.27
215
212.97
450K 0.65%
Nov 22, 2023 213.07 214.62
214.62
212.82
845K -0.51%
Nov 21, 2023 214.17 213.66
214.99
213
1.3M 1.10%
Nov 20, 2023 211.85 212.25
212.42
211.8
1.0M -0.07%
Nov 17, 2023 212 212.8
213
211.77
1.3M -0.43%
Nov 16, 2023 212.91 212.59
213.44
212
898K 0.40%
Nov 15, 2023 212.07 213.09
214
211.88
1.3M -0.88%
Nov 14, 2023 213.95 214
214.5
213.14
1.2M 0.35%
Nov 13, 2023 213.2 213.5
213.71
212.66
630K -0.24%
Nov 10, 2023 213.72 213.3
214.38
212.75
1.4M 0.37%
Nov 9, 2023 212.94 213.1
213.88
212.39
952K -0.39%
Nov 8, 2023 213.77 215
215
213.05
918K -0.08%
Nov 7, 2023 213.95 214.24
214.73
213.57
1.2M -0.14%
Nov 6, 2023 214.24 214.92
215.5
213.98
941K -0.35%
Nov 3, 2023 215 214.74
215.8
214.7
959K 0.10%
Nov 2, 2023 214.79 213.65
214.85
213.65
856K 0.20%
Nov 1, 2023 214.37 213.5
215
212.9
1.7M 0.73%
Oct 31, 2023 212.81 214.59
214.59
212.79
1.6M -0.63%
Oct 30, 2023 214.15 214.67
215.14
214.01
1.0M -0.21%
Oct 27, 2023 214.6 215.75
215.99
214.42
1.0M -0.5%
Oct 26, 2023 215.68 216.61
216.88
215.55
1.2M -0.44%
Oct 25, 2023 216.64 217.5
217.51
216.49
1.1M -0.37%
Oct 24, 2023 217.45 216.87
217.45
216.6
699K 0.27%
Oct 23, 2023 216.87 216.59
217.27
215.36
1.3M 0.64%
Oct 20, 2023 215.5 215.43
215.95
215.05
2.1M 0.25%
Oct 19, 2023 214.97 215.01
216.86
213.51
2.7M 0.06%
Oct 18, 2023 214.85 215.4
215.84
214.77
1.4M -0.23%
Oct 17, 2023 215.34 214.83
216.08
214.07
1.7M 0.20%
Oct 16, 2023 214.91 214.6
215.19
214.41
1.5M 0.41%
Oct 13, 2023 214.03 214.63
214.95
213.95
1.5M -0.2%
Oct 12, 2023 214.46 214.5
215.31
214.26
1.3M -0.02%
Oct 11, 2023 214.5 214.62
214.83
214.11
745K 0.05%
Oct 10, 2023 214.39 214.15
214.83
214
1.1M -0.05%
Oct 9, 2023 214.5 213.49
215.6
213.47
1.4M 0.46%
Oct 6, 2023 213.52 213.88
214.32
213.48
1.3M -0.13%
Oct 5, 2023 213.79 213.84
214.11
213.27
1.8M 0.02%
Oct 4, 2023 213.75 213.15
214.78
211.88
1.8M 0.58%
Oct 3, 2023 212.51 211.74
213.08
211.6
1.1M 0.36%
Oct 2, 2023 211.74 212.08
213.24
211
1.6M -0.19%
Sep 29, 2023 212.15 212.12
213.5
212.12
1.3M -0.04%
Sep 28, 2023 212.24 212.9
212.97
212.15
1.3M -0.15%
Sep 27, 2023 212.55 215
215
212.23
3.4M -1.67%
Sep 26, 2023 216.16 215.75
217.08
215.33
2.9M 0.30%
Sep 25, 2023 215.52 213.22
215.7
213.22
1.9M 0.85%
Sep 22, 2023 213.7 213.8
214
213.2
3.2M 3.54%
Sep 21, 2023 206.39 206.5
207.54
206
720K -0.29%
Sep 20, 2023 206.99 208.1
208.31
206.99
1.7M 0%